Non-Interventional Study of Zoladex in Endometriosis

AstraZeneca

Status: Completed

Conditions: Endometriosis

Study type: Observational

Funder types: Industry

Identifiers

NCT00938496

NIS-OCN-ZOL-2009/1

Details and patient eligibility

About

This is a prospective, open label NIS, which is to assess the efficacy of Zoladex in adjuvant setting after operation in moderate to severe endometriosis patients.

Enrollment: 408 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Advanced endometriosis confirmed histologically (r-AFS score III-IV) with conservative laparoscopy or laparotomy.
• Patient who has the indication of Zoladex and has been prescribed Zoladex according to physician's judgement, irrespective of the inclusion in the study.
• Patient has been already prescribed Zoladex within 1 month after operation.

Exclusion criteria

• Have used hormone treatment prior to 3 months of recruitment.
• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
• Previous enrolment in the present study.